Neurological Biomarkers Are Situated In the Cerebral Spinal Fluid of the Body and Are Most of the Time Cannot Be Detected In Blood

 

Neurological Biomarkers

Neurological biomarkers are being researched and developed all over the world, including in regions such as Germany, Mexico, and Japan. Neurological biomarkers are the specific proteins in the cerebrospinal fluid (CSF) that can indicate the presence of neurological disorders. They are mostly cross-functional and can be found in many tissues throughout the body. Neurological biomarkers assist in the diagnosis of nervous system disorders and monitor disease progression in patients with neurological diseases. Neurological biomarkers are usually expressed in a stepwise manner on cells. If these chemicals are found in high concentration in a tissue, it indicates that it is involved in neurological disease.

A recent study has provided insights on the usage of neurological biomarkers in Alzheimer's Disease. The researchers studied two sets of elderly adults with Alzheimer's Disease. Surprisingly, the researchers found a significantly higher prevalence of neurological biomarkers in Alzheimer's Disease patients than in controls. Moreover, there is a significant association between the abundance of these chemicals in the brain and the severity of cognitive impairment in patients with Alzheimer's. In regions such a Germany, the increasing prevalence of neurological disorders such as Alzheimer's has increased the researches related to neurological biomarkers. For instance, according to Alzheimer's Association, in Germany, over 1.5 million individuals suffer from Alzheimer's disease.

The neurological biomarkers market is showing tremendous potential for clinical research and trials. The studies have been performed and are currently being conducted to find the correlation between nutritional supplementation and Alzheimer's Disease. The studies are also being performed to find the usefulness of anti-oxidants in treating different neurological diseases. Most importantly, more focus is being placed on the screening of normal biological compounds, especially those which are within the pharynx, in order to determine their toxicity when exposed to toxic substances. There are a number of possibly toxic substances present in foods today that we consume unconsciously. The neurological biomarkers market is providing a great service to medical science. Although this market is rapidly growing, it is still lagging behind in terms of availability. According to reports, there are still millions of people who are affected by Alzheimer's Disease and are yet to be diagnosed or are experiencing early-onset dementia.


Comments

Popular posts from this blog

Bell shaped pepper is a member of the Capsicum Baccatum species, which includes the Ají pepper

Light Linear Alpha Olefins Are Produces through Oligomerization of Ethylene and by Fischer-Tropsch Synthesis

How is Tissue Banking Beneficial to People with Severe Morbidity, Chronic Diseases, and Organ Transplant Surgery?